Status:
UNKNOWN
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Lead Sponsor:
Olive Lifesciences Pvt Ltd
Conditions:
Chronic Smokers
Hyperlipidemia
Eligibility:
MALE
20-65 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having ...
Detailed Description
In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers having mild to moderat...
Eligibility Criteria
Inclusion
- Men \> 20 years
- Chronic cigarette/ beedi smoker (2-3 packets/day since last 3 years or more) with mild to moderate hyperlipidemia (LDL ranging 160-189 mg/dL, TC \>200 mg/dL and/or HDL-C \<40 mg/dL)
- Being mentally competent and able to understand all study requirements and sign the informed consent form.
Exclusion
- Patients with Chronic obstructive pulmonary disease (COPD)
- Women
- Patients with severe liver, renal, cardiac or brain diseases.
- Unable to complete follow up.
- Subjects on any medication like diuretics.
- Allergic to any medication.
- With a history of alcohol and/or drug abuse.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02203227
Start Date
August 1 2014
End Date
February 1 2015
Last Update
July 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sreenivasa Clinic Diabetic Research Center
Bangalore, Karnataka, India, 560050